Capital Research Global Investors
MDLN

Capital Research Global Investors’s Medline Inc MDLN Stock Holding History

Capital Research Global Investors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58B Buy
39,963,790
+16,802,120
+73% +$677M 0.22% 94
2026
Q1 		$1.03B Buy
23,161,670
+8,377,467
+57% +$370M 0.16% 115
2025
Q4 		$621M Buy
+14,784,203
New +$624M 0.11% 132

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors's MDLN Position: Q2 2026 in Review

Capital Research Global Investors increased its Medline Inc (MDLN) stake by 73% in Q2 2026, buying an estimated $677M and bringing the position to 39,963,790 shares worth $1.58B. The position accounts for 0.22% of the portfolio, ranked #94.

Capital Research Global Investors first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Capital Research Global Investors held 39,963,790 shares of Medline Inc worth $1.58B as of Q2 2026.
  • Capital Research Global Investors bought 16,802,120 Medline Inc shares in Q2 2026, an estimated $677M.
  • Medline Inc made up 0.22% of Capital Research Global Investors's portfolio in Q2 2026, its #94 holding.
  • Capital Research Global Investors first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Capital Research Global Investors's 13F filing for Q2 2026, filed 12 Aug 2026.